Join Shaji Kumar and guests to hear the latest on AL amyloidosis from both healthcare professional and patient perspectives.
These podcasts are intended for healthcare professionals only.
Episode 7: Defining subgroups in treatment: Stratification and personalized care
Episode 7. As the treatment landscape for AL amyloidosis evolves, translating prognostic data into day-to-day clinical decision-making remains a key challenge. Shaji Kumar and Anita D’Souza return to discuss how risk stratification is shaping individualized care across the patient journey. Drawing on emerging evidence and real‑world practice, D’Souza notes that “AL amyloidosis is certainly not a one‑size‑fits‑all disease,” underscoring the importance of personalized, multidisciplinary management.
9 Feb 2026
Episode 6: Evolving diagnostic practices in AL amyloidosis
Diagnostic delays remain a defining challenge in AL amyloidosis, where subtle red flags are often misattributed to far more common conditions. Vaishali Sanchorawala and Shaji Kumar explore the practical steps clinicians can take to recognize AL amyloidosis earlier in the diagnostic journey. Their conversation examines how to heighten clinical suspicion, optimize the use of surrogate biopsy sites, and navigate the increasingly complex landscape of amyloid typing.
9 Feb 2026
Episode 5: Clinical trials and emerging therapies: Bridging innovation and access
As therapeutic innovation accelerates in AL amyloidosis, clinicians are confronted with a rapidly shifting treatment landscape. Taxiarchis Kourelis joins Shaji Kumar to examine how emerging modalities, including cellular therapies, targeted agents and organ directed approaches aimed at amyloid clearance, may reshape long held treatment principles. Kourelis reflects on the evolving role of transplant, the promise and pitfalls of immunotherapy based approaches, and the practical realities of treatment accessibility.
10 Mar 2025
Episode 4: Not a one-size-fits-all approach: Treatment and management of AL amyloidosis
While myeloma is used as a blueprint for treatment of AL amyloidosis, it does not truly reflect its complexity. Dr Anita D’Souza and Dr Kumar discuss the role of clinical trials, the use of autologous stem cell transplant, and how the nature of AL amyloidosis alters response to and side effect profiles of myeloma treatments. Dr D’Souza also offers advice on monitoring treatment response and the steps to take when response is poor.
4 Mar 2025
Episode 3: The long road to diagnosis of AL amyloidosis
Dr Anita D’Souza returns to discuss the complex process of identifying and confirming AL amyloidosis. She talks to Dr Kumar about how she uses tests – from blood tests to mass cytometry – in the diagnostic process, why a negative biopsy does not always rule out AL amyloidosis, and why a multidisciplinary approach is critical for good patient outcomes.
20 Jan 2025
Episode 2: The many faces of AL amyloidosis
Episode 2. AL amyloidosis can present with an astonishing variety of symptoms that masquerade as other diagnoses, making it very easy to miss. Dr Kumar and Dr Anita D’Souza chat about how to recognise when there could be a single underlying cause of accumulating diverse symptoms – and why it’s so important to consider the whole patient to avoid diagnostic delay. Dr D’Souza also talks about strategies for identifying and managing AL amyloidosis coexisting with multiple myeloma.
15 Nov 2024
Episode 1: Beyond the diagnosis – Patient voices and holistic care
Dr. Kumar speaks with patient Linda Perez about the physical and emotional impact of AL amyloidosis and the importance of holistic care and specialist collaboration.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
2 ratings
Spotify
5.0 / 5
1 ratings
Podcast Authority Score: 9 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
6
Social presence
0
YouTube
0
Engagement
32
Contact Navigating AL amyloidosis
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Navigating AL amyloidosis?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
